Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION (Details Narrative)

v3.21.2
BASIS OF PRESENTATION (Details Narrative)
6 Months Ended
Jul. 17, 2019
shares
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Variable Interest Entity [Line Items]      
Net decrease to cash flow used by operating activities   $ (1,719,000) $ (1,260,000)
Restatement Adjustment [Member]      
Variable Interest Entity [Line Items]      
Net decrease to cash flow used by operating activities     923,000
Restatement Adjustment [Member] | EJ Holding, Inc. [Member]      
Variable Interest Entity [Line Items]      
Net decrease to cash flow used by operating activities     $ (953,000)
Emmaus Life Sciences, Inc. [Member]      
Variable Interest Entity [Line Items]      
Reverse stock split 1-for-6    
Reverse stock split, conversion ratio 0.167    
Telemynd [Member]      
Variable Interest Entity [Line Items]      
Common stock shares, Stock split ratio | shares 1